EG110A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EG110A, covering 2025-11-12 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization [Phase 1, Phase 2]